Harald Klüter

Vorsitz
Zeit Titel der Session  
24.09.2021
08:30 – 09:30

Anämie
Abstracts (Beteiligung als Autor)
Zeit ID Programmpunkt  
22.09.2021
P13 
Introduction of gene panel sequencing for immunohematologic case work
22.09.2021
P35 
The ABO c.1061C>del variant for blood group A(2) is associated with the risk for COVID-19
22.09.2021
P42 
Collection of Covid-convalescent plasma in Germany 2020-2021
22.09.2021
13:00–13:10
VS-6-1 
Transfused COVID-19 convalescent plasma in the randomized clinical trial CAPSID
22.09.2021
13:40–13:50
VS-4-4 
Donor satisfaction with the german blood donor questionnaire
22.09.2021
16:30–16:40
VS-8-5 
Towards an advanced flow cytometric characterization of HSC subpopulations in cryopreserved autologous PBSC preparations
23.09.2021
09:10–09:20
VS-12-3 
Repeated helicopter transport of red cell concentrates for prehospital transfusion is feasible for up to 42 days
23.09.2021
15:30–15:35
PS-1-1 
How does the Corona pandemic impact on whole blood donation in Germany?
23.09.2021
15:50–15:55
PS-5-5 
Long-term course of antibody titres in convalescent plasma donors and the potential influence of plasma donations – An investigation project within the framework of the CORE-Study (COVID-19 convalescent plasma of adults)
23.09.2021
16:15–16:20
PS-2-10 
Titanium nanoparticles enhance production and suppress clearance of GDF15 in human primary macrophage
23.09.2021
16:15–16:20
PS-5-10 
SARS-CoV-2 convalescent plasma donors in Germany – Statistical analyzes of anamnestic and epidemiological data and differences between the three waves of infection. An investigational project within the framework of the CORE-Study (COVID-19 convalescent plasma of adults)